loading
전일 마감가:
$2.36
열려 있는:
$2.43
하루 거래량:
556.32K
Relative Volume:
0.81
시가총액:
$193.75M
수익:
$63.63M
순이익/손실:
$10.62M
주가수익비율:
48.50
EPS:
0.05
순현금흐름:
$-8.64M
1주 성능:
-6.92%
1개월 성능:
+33.70%
6개월 성능:
+0.41%
1년 성능:
+124.07%
1일 변동 폭
Value
$2.36
$2.473
1주일 범위
Value
$2.36
$2.655
52주 변동 폭
Value
$1.01
$3.10

Protalix BioTherapeutics Inc. Stock (PLX) Company Profile

Name
명칭
Protalix BioTherapeutics Inc.
Name
전화
972 4 988 9488
Name
주소
2 Snunit Street, Science Park PO Box 455, Karmiel
Name
직원
190
Name
트위터
@Protalix_Bio
Name
다음 수익 날짜
2025-03-17
Name
최신 SEC 제출 서류
Name
PLX's Discussions on Twitter

PLX을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PLX
Protalix BioTherapeutics Inc.
2.43 188.17M 63.63M 10.62M -8.64M 0.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
408.60 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
472.79 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.54 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
801.70 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
331.41 35.16B 4.56B -176.77M 225.30M -1.7177

Protalix BioTherapeutics Inc. Stock (PLX) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2020-06-08 재확인 H.C. Wainwright Buy
2017-04-17 재확인 Rodman & Renshaw Buy
2016-04-04 개시 Rodman & Renshaw Buy
2015-04-23 업그레이드 Jefferies Hold → Buy
2014-11-12 재확인 R. F. Lafferty Buy
2014-01-24 개시 R. F. Lafferty Buy
2012-05-02 다운그레이드 Canaccord Genuity Buy → Hold
2012-05-02 재확인 Oppenheimer Outperform
2012-04-30 다운그레이드 Auriga Buy → Hold
2011-10-13 개시 Morgan Joseph Hold
2011-03-17 다운그레이드 WBB Securities Strong Buy → Buy
2010-11-09 재확인 Oppenheimer Outperform
2010-10-14 재확인 UBS Buy
2009-12-02 재확인 Hapoalim Outperform
2009-09-22 개시 Canaccord Adams Buy
2009-09-02 개시 Hapoalim Outperform
2008-12-01 재확인 Oppenheimer Outperform
2008-03-11 개시 UBS Buy
2007-11-20 개시 CIBC Wrld Mkts Sector Outperform
모두보기

Protalix BioTherapeutics Inc. 주식(PLX)의 최신 뉴스

pulisher
10:55 AM

How Protalix BioTherapeutics Inc. stock performs in weak economy2025 Key Highlights & Low Risk Investment Opportunities - newser.com

10:55 AM
pulisher
10:33 AM

Published on: 2025-10-13 09:33:20 - newser.com

10:33 AM
pulisher
10:27 AM

How to use Fibonacci retracement on Protalix BioTherapeutics Inc.July 2025 Market Mood & Low Risk High Reward Trade Ideas - newser.com

10:27 AM
pulisher
10:17 AM

Is Protalix BioTherapeutics Inc. stock positioned for long term growthJuly 2025 Levels & Weekly High Return Opportunities - newser.com

10:17 AM
pulisher
09:54 AM

Will breakout in Protalix BioTherapeutics Inc. lead to full recoveryWeekly Earnings Recap & Real-Time Chart Breakout Alerts - newser.com

09:54 AM
pulisher
07:59 AM

Relative strength of Protalix BioTherapeutics Inc. in sector analysisJuly 2025 Decliners & Growth Oriented Trading Recommendations - newser.com

07:59 AM
pulisher
Oct 12, 2025

Earnings visualization tools for Protalix BioTherapeutics Inc.Earnings Growth Report & Expert Verified Movement Alerts - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

Can trapped investors hope for a rebound in Protalix BioTherapeutics Inc.2025 Price Targets & Safe Entry Momentum Stock Tips - newser.com

Oct 11, 2025
pulisher
Oct 10, 2025

Can Protalix BioTherapeutics Inc. hit a new high this monthTrade Performance Summary & Smart Swing Trading Techniques - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Visual analytics tools that track Protalix BioTherapeutics Inc. performanceChart Signals & Capital Protection Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Why Protalix BioTherapeutics Inc. stock could benefit from AI revolutionEarnings Recap Report & Low Risk Entry Point Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Why Protalix BioTherapeutics Inc. (DE) stock appears on watchlistsJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is Protalix BioTherapeutics Inc. (PBDA) stock considered safe haven2025 Key Lessons & Fast Gain Stock Tips - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is this a good reentry point in Protalix BioTherapeutics Inc.July 2025 Retail & Growth Focused Stock Reports - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

What analysts say about Protalix BioTherapeutics Inc stockSwing Trading Ideas & Next-Level Stock Intelligence, Now Free - earlytimes.in

Oct 07, 2025
pulisher
Oct 06, 2025

Is it too late to sell Protalix BioTherapeutics Inc.Weekly Investment Report & Fast Moving Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What the charts say about Protalix BioTherapeutics Inc. todayJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Why Protalix BioTherapeutics Inc. (PBDA) stock gets analyst attention2025 Big Picture & Long-Term Growth Stock Strategies - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Protalix BioTherapeutics Inc. (DE) stock undervalued after correctionWeekly Earnings Recap & Long-Term Investment Growth Plans - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Statistical indicators supporting Protalix BioTherapeutics Inc.’s strengthEarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Developing predictive dashboards with Protalix BioTherapeutics Inc. dataJuly 2025 Decliners & Long-Term Growth Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Detecting price anomalies in Protalix BioTherapeutics Inc. with AIWeekly Stock Summary & Verified Entry Point Signals - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-02 23:31:20 - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Published on: 2025-10-02 21:05:30 - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Published on: 2025-10-01 07:13:09 - newser.com

Oct 01, 2025

Protalix BioTherapeutics Inc. (PLX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$84.79
price up icon 1.24%
$22.99
price up icon 7.56%
$32.66
price up icon 2.62%
$102.75
price up icon 0.67%
$164.51
price up icon 1.41%
biotechnology ONC
$331.45
price up icon 3.42%
자본화:     |  볼륨(24시간):